Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vitali Verin

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Angiology|October 21, 2003
In-hospital complications of percutaneous intraaortic balloon counterpulsationAdalberto Arceo, Philip Urban, Pierre-André Dorsaz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2002
Heterogeneity of smooth muscle cell populations cultured from pig coronary arteryHiroyuki Hao, Patricia Ropraz, Vitali Verin, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 18, 2009
Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trialAhmed A Khattab, Gert Richardt, Vitali Verin, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Angiology|October 21, 2003
In-hospital complications of percutaneous intraaortic balloon counterpulsationAdalberto Arceo, Philip Urban, Pierre-André Dorsaz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2002
Heterogeneity of smooth muscle cell populations cultured from pig coronary arteryHiroyuki Hao, Patricia Ropraz, Vitali Verin, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 18, 2009
Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trialAhmed A Khattab, Gert Richardt, Vitali Verin, et al.
Pageof 2